Voloridge Investment Management, LLC Prothena Corp Public LTD CO Transaction History

Voloridge Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$30.27 - $49.22 $4.41 Million - $7.16 Million	-145,551 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$42.11 - $73.26 $770,360 - $1.34 Million	18,294 Added 14.38%	145,551 $7.19 Million
Q3 2021 Nov 15, 2021	BUY	$48.2 - $78.89 $2.49 Million - $4.07 Million	51,596 Added 68.19%	127,257 $9.07 Million
Q2 2021 Aug 16, 2021	BUY	$21.63 - $57.65 $1.64 Million - $4.36 Million	75,661 New	75,661 $3.89 Million

185

42.8M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $668M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.